Calix Ltd (ASX: CXL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Calix Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $156.70 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 182.20 million
Earnings per share -0.144
Dividend per share N/A
Year To Date Return -76.53%
Earnings Yield N/A
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Calix Ltd (ASX: CXL)
    Latest News

    A wide-smiling businessman in suit and tie rips open his shirt to reveal a green t-shirt underneath
    Technology Shares

    Guess which ASX 300 stock is rocketing 15% today

    What is getting investors excited today? Let's find out.

    Read more »

    Man pointing at a blue rising share price graph.
    Share Market News

    Why Calix, Collins Foods, Myer, and Patriot Battery Metals shares are charging higher

    Four ASX shares are rising more than most today.

    Read more »

    Vanadium Resources share price person riding rocket indicating share price increase
    Technology Shares

    Guess which ASX tech stock could double in value

    This highly speculative stock could offer big returns according to one broker.

    Read more »

    Person handing out $50 notes, symbolising ex-dividend date.
    Share Market News

    Insiders are buying Mesoblast and these ASX shares

    Insiders seem to see value in these shares.

    Read more »

    A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
    Share Gainers

    Why Calix, Genex, Life360, and Spartan Resources shares are rising

    These ASX shares are starting the week on a positive note. But why?

    Read more »

    a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
    Technology Shares

    Guess which ASX tech stock is jumping 15% today

    Investors are cheering an update on a major project.

    Read more »

    a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
    Share Fallers

    Why Ampol, Calix, Collins Foods, and Propel shares are tumbling today

    These ASX shares are ending the week in the red. But why?

    Read more »

    Person pointing at an increasing blue graph which represents a rising share price.
    Share Gainers

    Why Audinate, Beach Energy, Calix, and JB Hi-Fi shares are charging higher

    These ASX shares are starting the week in a positive fashion. But why?

    Read more »

    Worried ASX share investor looking at laptop screen
    Share Fallers

    Why Boss Energy, Calix, Frontier Digital, and Gold Road shares are falling today

    These ASX shares are having a tough time on Monday. But why?

    Read more »

    A man in a suit face palms at the downturn happening with shares today.
    Materials Shares

    Why is this ASX All Ords share plunging 30% on Monday?

    Investors haven't responded well to the release of an announcement this morning.

    Read more »

    Contented looking man leans back in his chair at his desk and smiles.
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    Here's what brokers are recommending as buys this week.

    Read more »

    A man sees some good news on his phone and gives a little cheer.
    Share Gainers

    Why Calix, Chrysos, Inghams, and Life360 shares are pushing higher today

    These ASX shares are having a good session. Let's find out why.

    Read more »

    Frequently Asked Questions

    Calix Ltd does not pay shareholder dividends at this time. 

    Calix listed on the ASX on 20 July 2018.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    26 Sep 2005 $0.0150 100.00% Final 07 Oct 2005

    CXL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Calix Ltd

    Calix Ltd (ASX: CXL) is an Australian technology company. It has developed a patented, platform technology that essentially involves grinding minerals to between one-hundredth and one-thousandth of a millimetre in size, and then "flash" heating them in a reactor. As trapped gases in the minerals are released, they create highly porous honeycomb-like structures with similar properties to nanomaterials, but without the associated safety issues and costs. Calix's technology also allows for the separation of carbon dioxide, making it attractive to industries and companies looking to reduce carbon emissions.

    Calix's technology is being used globally across many industries and sectors. These include advanced battery development, water and wastewater treatment, sustainable food, and biotechnology. The company has operations in Australia, New Zealand, Asia, Europe, and the United States.

    CXL Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    25 Nov 2024 $0.89 $0.09 11.18% 107,522 $0.83 $0.89 $0.80
    22 Nov 2024 $0.81 $0.01 1.25% 241,270 $0.81 $0.83 $0.80
    21 Nov 2024 $0.80 $-0.01 -1.24% 175,788 $0.81 $0.83 $0.80
    20 Nov 2024 $0.81 $-0.04 -4.71% 242,974 $0.84 $0.88 $0.81
    19 Nov 2024 $0.85 $0.01 1.19% 76,881 $0.84 $0.86 $0.83
    18 Nov 2024 $0.84 $0.00 0.00% 130,830 $0.84 $0.87 $0.83
    15 Nov 2024 $0.84 $-0.04 -4.57% 423,122 $0.86 $0.89 $0.84
    14 Nov 2024 $0.88 $0.03 3.53% 153,720 $0.87 $0.92 $0.86
    13 Nov 2024 $0.85 $0.02 2.41% 203,122 $0.84 $0.91 $0.84
    12 Nov 2024 $0.83 $-0.01 -1.20% 74,476 $0.83 $0.86 $0.83
    11 Nov 2024 $0.84 $-0.02 -2.35% 248,034 $0.84 $0.88 $0.83
    08 Nov 2024 $0.85 $0.04 4.97% 72,443 $0.82 $0.85 $0.82
    07 Nov 2024 $0.81 $-0.01 -1.23% 408,753 $0.82 $0.85 $0.78
    06 Nov 2024 $0.82 $0.00 0.00% 94,890 $0.82 $0.85 $0.81
    05 Nov 2024 $0.82 $-0.03 -3.55% 134,780 $0.86 $0.86 $0.82
    04 Nov 2024 $0.85 $-0.05 -5.62% 298,909 $0.90 $0.90 $0.83
    01 Nov 2024 $0.89 $0.01 1.13% 115,098 $0.90 $0.91 $0.86
    31 Oct 2024 $0.89 $0.04 4.71% 478,280 $0.85 $0.90 $0.85
    30 Oct 2024 $0.85 $-0.15 -15.08% 1,728,918 $0.78 $0.87 $0.73
    29 Oct 2024 $1.00 $-0.05 -4.81% 277,622 $1.02 $1.04 $0.99

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    03 May 2024 Sarah Ryan Buy 10,000 $13,500
    On-market trade.
    10 Apr 2024 Sarah Ryan Buy 10,000 $14,950
    On-market trade.
    12 Mar 2024 Catriona Deans Buy 50,000 $86,500
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Catriona Alison Deans Non-Executive DirectorNon-Executive Chairman Mar 2023
    Ms Deans is also a member of the Investment Committee at Main Sequence Ventures (CSIRO's innovation fund) and a Member of the AICD Corporate Governance Committee. Alison's previous directorships include Westpac Banking Corporation, Insurance Australia Group Limited and Social Ventures Australia. In her executive career, Alison was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas, CEO of netus Pty Ltd (a technology investment company acquired by Fairfax), and a consultant with McKinsey & Company. She is member of Risk Management Committee and the Sustainability Committee.
    Ms Helen E Fisher Non-Executive Director Sep 2020
    Ms Fisher is Managing Director and CEO of Bio Capital Impact Fund (BCIF). Prior to establishing BCIF, Helen was a partner of Deloitte for over 10 years and led Deloitte's Life Sciences industry practice in Australia for five years, having had many years of experience in the Life Sciences and Health Care industry. She also specialized in Financial Services, servicing some of the Australian banks and funds and has been involved in setting up several international funds, as well as advised on several M&A deals. Helen provided strategic advice to publicly listed multinational companies and has experience with capital raisings, licensing deals, demergers, implementing offshore expansions. She is Chair of the Risk Management Committee and member of the Sustainability Committee.
    Mr Lance Adrian Wingate O'Neill Non-Executive Director Feb 2014
    Lance O'Neill is a Director of DFB (Australia) Pty Ltd, a Sydney based investment advisory business, and has worked in institutional equity, fixed income sales/trading and corporate finance in international securities and investment markets for over thirty years predominantly in Australia, UK and USA. He is the chair of MediaZest Plc and EP&F Capital Plc and in addition is and has been a director of, and investor in, a number of private and public companies in Australia, UK, and the USA.
    Dr Mark Geoffrey Sceats Chief ScientistExecutive Director Feb 2014
    Dr Sceats has previously worked at the James Franck Institute at the University of Chicago, and a Research Associate, and as an Assistant Professor of the University of Rochester NY, USA, where he was awarded the Alfred P Sloan Fellowship for his work. Later he was employed by the University of Sydney as a Reader in the School of Chemistry for his research work on chemical reaction kinetics and led the Australian Photonics CRC from 1991-2004. He is also member of the Technology Committee.
    Dr Philip (Phil) Hargraves Hodgson Chief Executive OfficerManaging Director Feb 2014
    Dr Hodgson has a technical and commercial background from a career with Shell, where for over 14 years he developed depth of experience across all sectors of the downstream oil industry, including refining and supply, marketing and sales, pricing strategy, risk management, corporate strategy, and mergers and acquisitions. From 2007 to 2013, Phil ran his own consultancy, providing project development, commercial, M&A, and management expertise to several sectors, including LNG, biofuel, clean coal, geothermal energy, building products, logistics and fast-moving consumer goods. He is also member of Technology Committee.
    Dr Sarah Elizabeth Ryan Non-Executive Director Jan 2024
    Dr Ryan brings global engineering and commercial experience, encompassing private equity, investment management, energy sector operations, marketing, research, and team management. With a particular emphasis on innovation and technology enabled solutions. Dr Ryan is also a Strategic Advisory Panel Member of the ARC Centre of Excellence for Green Electrochemical Transformation of Carbon Dioxide and Chair of the Energy Forum for the Australian Academy of Technological Sciences and Engineering.
    Mr Peter Matthew Francis Dixon Non-Executive Director Jan 2024
    Mr Dixon has 25 years of experience across the legal, investment banking and funds management sectors, Mr Dixon brings expertise across corporate strategy, investment management, corporate advisory (including equity capital markets) and legal governance issues to the Calix board. Mr Dixon is currently Chief Strategy Officer for HPX. Mr Dixons investment banking and legal experience includes private legal practice experience at Mallesons Stephen Jacques in Sydney and Linklaters in London, as well as over nine years executive experience as an investment banker.
    Mr Darren Charles Chief Financial OfficerCompany Secretary
    -
    Darren Charles Chief Financial OfficerCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    J P Morgan Nominees Australia Pty Limited 37,306,915 20.49%
    HSBC Custody Nominees (Australia) Limited 16,902,940 9.29%
    UBS Nominees Pty Ltd 14,434,134 7.93%
    Nicholas Merriman 8,108,286 4.45%
    Citicorp Nominees Pty Limited 6,978,187 3.83%
    Mr Paul Crowther 5,389,438 2.96%
    Mark Geoffrey Sceats <Sceats Superannuation Fund> 2,847,344 1.56%
    Dr Mark Geoffrey Sceats 2,732,119 1.50%
    Pigeons Super Pty Limited <The Hodgson Family S/F A/C> 2,196,597 1.21%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 1,889,808 1.04%
    UBS Nominees Pty Ltd i 1,773,836 0.97%
    Mr Jacob Shields Ulrich 1,533,133 0.84%
    HSBC Custody Nominees (Australia) Limited A/C 2 1,497,250 0.82%
    Phil Hodgson 1,311,148 0.72%
    Jeneil Super Pty Ltd <Jeneil Super Fund A/C> 1,266,387 0.70%
    Mr John Andrew Hamilton 1,223,639 0.67%
    Turnbull Super Fund Pty Ltd <The Turnbull Super Fund A/C> 1,133,789 0.62%
    Mr Maxwell Oliver Crowther 1,000,000 0.55%
    Mr Oliver Marcus Crowther 1,000,000 0.55%
    Ms Megan Olivia Crowther 1,000,000 0.55%

    Profile

    since

    Note